A Peter Mac-initiated clinical trial suggests a way to dramatically improve outcomes in patients with high-risk forms of ...

For many patients with schizophrenia, other psychiatric illnesses, or diseases such as hypertension and asthma, it can be ...

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid ...

As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading ...

Digital innovations such as ePRO and eCOA are streamlining clinical trials, boosting participant engagement, and improving ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

By Dennis Thompson HealthDay ReporterTUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic /Wegovy and ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Francisco de Souza, Hugo. (2025, June 04). AI-designed drug shows early promise for lung fibrosis ...

The effect of Novo Nordisk’s amycretin injections on body weight showed no signs of plateauing after 36 weeks, suggesting the ...

Atrogi's breakthrough discovery enables chronic use of next-generation, highly selective β2-agonists for the first time in metabolic disease ...

Alexander D. Sherry “The primary endpoints that we select for phase 3 trials will be used to determine whether we move forward with a new drug or therapeutic strategy in clinical practice ...